Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04254497
What this trial is testing

A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer

Who this might be right for
Lung Cancer
Changi General Hospital 71
Not applicableStudy completedNCT03055923
What this trial is testing

EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.

Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease
Portsmouth Hospitals NHS Trust 149
Not applicableUnknownNCT03312374
What this trial is testing

CtDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 350
Large-scale testing (Phase 3)Looking for participantsNCT06948214
What this trial is testing

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency (GHD)
Lumos Pharma 150
Not applicableUnknownNCT03150849
What this trial is testing

C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Assiut University 50
Not applicableStudy completedNCT02333448
What this trial is testing

Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.

Who this might be right for
Invasive Candidiasis; Treatment With Echinocandin
Centre Hospitalier Universitaire Dijon 80
Not applicableStudy completedNCT05173415
What this trial is testing

Marker Technique Comparison in Targeted Axillary Dissection

Who this might be right for
Breast Cancer
Constanze Elfgen 40
Not applicableActive Not RecruitingNCT06850506
What this trial is testing

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Who this might be right for
SarcomaSarcoma, BoneEwing Sarcoma+1 more
Peking University People's Hospital 70
Not applicableUnknownNCT02278016
What this trial is testing

Biological Markers for the Diagnosis of Central Nervous System Infective Diseases

Who this might be right for
Infection
Xijing Hospital 150
Not applicableStudy completedNCT00899158
What this trial is testing

Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss

Who this might be right for
CachexiaPancreatic Cancer
Case Comprehensive Cancer Center 44
Not applicableUnknownNCT05946915
What this trial is testing

MiRNA as a Growth Plate Marker After GH

Who this might be right for
MicroRNAs: D13.444.735.790.552.500
Faculdade de Ciências Médicas da Santa Casa de São Paulo 30
Not applicableUnknownNCT05767814
What this trial is testing

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.

Who this might be right for
Psoriatic ArthritisRheumatoid Arthritis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Not applicableUnknownNCT00751452
What this trial is testing

Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children

Who this might be right for
Benign Disease
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Looking for participantsNCT07242352
What this trial is testing

Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC

Who this might be right for
Breast CancerHR+/HER2- Breast Cancer
Women's Cancer Study Group GmbH 1,520
Testing effectiveness (Phase 2)Study completedNCT03798743
What this trial is testing

Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Not applicableStudy completedNCT01567176
What this trial is testing

Circulating SIRT6 Expression, Effect on Aging Quality

Who this might be right for
Aging
Hospices Civils de Lyon 60
Not applicableStudy completedNCT03432091
What this trial is testing

Melatonin Receptor Agonist and Peripheral Biological Markers

Who this might be right for
Insomnia
National Science and Technology Council, Taiwan 40
Not applicableStudy completedNCT02303236
What this trial is testing

Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.

Who this might be right for
Heart Failure
Rigshospitalet, Denmark 25
Not applicableStudy completedNCT04467658
What this trial is testing

Neurophysiological Marker of ADHD in Children

Who this might be right for
Attention Deficit Hyperactivity DisorderPsychiatric DiagnosisDiagnosis, Psychiatric
Daegu Catholic University Medical Center 140
Not applicableLooking for participantsNCT03237026
What this trial is testing

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 360
Next Page